Hong Kong plans ‘to overtake Nasdaq’ as listing destination of choice for Chinese biotech firms

Wall Street cheers Hong Kong’s IPO rules revamp but sees New York’s dominance unthreatened Meanwhile, asked if the Shanghai bourse’s plan to allow non-mainland listed firms to issue shares traded in the mainland via the so-called Chinese Depository …
( read original story …)